2021 ASCO Virtual Direct™ Highlights


 

2021 ASCO Key Takeaways on Kidney & Bladder Cancers: Immuno-oncology, Avelumab in mUC, Adjuvant Pembrolizumab Following Surgery in High-Risk ccRCC

68 views
August 19, 2021
Comments 0
Login to view comments. Click here to Login